Patent Baristas

The Baristas had a post from Patent Baristas featured in the newly launched BlawgWorld 2006: Capital of Big Ideas, an eBook sampler of 51 of the most influential law blogs (blawgs). BlawgWorld is published by TechnoLawyer, a publisher of various e-mail newsletters for the legal marketplace. The Barista article, “Misconduct (and Not Just Scientific) is […]

We reported earlier that the U.S. Patent and Trademark Office (USPTO) issued a ruling against one of several patents that Pfizer holds on Lipitor (atorvastatin), its top-selling cholesterol drug. In the reexamination proceeding initiated last year by the Public Patent Foundation (“PUBPAT”), the USPTO rejected all 44 of the claims of U.S. patent 5,969,156 when […]

Yes, Blawg Review #34(!) is up over at Phosita, hosted by Douglas Sorocco. This is an awesome round-up of blawgs with lots of great posts – obviously the turkey hangover wasn’t too bad this year. We loved the post (of course) over on Brand Autopsy musing about the Lowest Common Coffee Denominator. So, is your […]

The accused infringers, AWH Corp., et al., have petitioned for review of one part of the en banc ruling on claim construction in the Phillips case. (I hardly can write a sentence without using Latin). Now that all the fanfare over the Federal Circuit’s consideration of that case, and over the 33 amici that weighed […]

CincyTechUSA announced that Robert W. Coy, Jr. of St. Louis joined the organization as president. Coy was senior vice president for Entrepreneurial Development for the St. Louis Regional Chamber and Growth Association. He replaces Rich Kiley, who has served as interim executive director of CincyTechUSA since May of 2004. CincyTechUSA focuses on assisting companies in […]

In Invitrogen Corporation v. Clontech Laboratories, Inc., Fed. Cir. 04-1039, -1040 (November 18, 2005), the CAFC vacated an invalidity judgment and the district court’s conception ruling based on anticipation by § 102(g)(2) prior art where the inventors could not appreciate the discovery they made. Invitrogen appealed from a decision by the United States District Court […]

Among the most frequently asked questions I get from start-up companies is: How much should I pay for licensing in a technology? Answer: As little as possible. Kidding aside, this is really a very complicated question that cannot be answered without a lot of homework. While most companies seem to use a valuation method I […]

Red Herring this week ran an interesting article about a company called PeopleConnect. Basically, PeopleConnect helps high-tech startups hire pricey executives without actually having to pay them any cash. Angel Employees, like Angel Investors, invest their labor in exchange for an equity stake in the company. The companies, meanwhile, get top notch management while keeping […]